What are the serious side effects of Anamorelin?

Anamorelin (Anamorelin) has shown significant efficacy in improving cancer wasting syndrome, but patients may still experience serious or potentially risky adverse reactions during use, so high attention and strict monitoring are required in clinical application.

First, anamorelin may cause increases in blood sugar or blood sugar fluctuations, which is particularly important in patients with diabetes or insulin resistance. Patients need to regularly monitor fasting and postprandial blood sugar during medication to prevent hyperglycemia or related metabolic complications, and at the same time adjust their diet or insulin treatment plan according to changes in blood sugar.

Secondly, anamorelin may increase cardiovascular risks, including palpitations, arrhythmia, blood pressure fluctuations and a small number of cardiovascular events. Especially in high-risk groups, drugs can cause electrocardiogramQT interval prolongation. Therefore, it is recommended to conduct baseline electrocardiogram testing before medication, and to monitor heart rate and blood pressure changes at regular follow-up during treatment.

In addition, anamorelin may have an impact on liver function, including increased transaminases and abnormal liver function indicators. Liver function tests need to be performed regularly during treatment to avoid drug-induced liver injury. Other common side effects include edema, gastrointestinal discomfort, nausea, headache, and mild fatigue. Although these symptoms are not necessarily life-threatening, they may affect the patient's quality of life and medication compliance. Long-term or high-dose use may increase the risk of cardiovascular events or cause metabolic abnormalities. Patients who are frail or have underlying diseases need to be more cautious.

In clinical applications, in order to ensure safety and efficacy, doctors usually develop personalized medication plans based on individual patient conditions, including dose adjustment, combination therapy, nutritional intervention and regular follow-up. Monitoring content includes weight, lean body mass, blood sugar, liver function, electrocardiogram and blood pressure, etc., in order to detect and deal with adverse events in a timely manner. At the same time, patients should strictly follow the doctor's instructions to take medication, not increase the dose or stop medication at will, and provide symptom management and supportive treatment when necessary.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/